Sichuan Department of human resources and social security informed CML life medicine to be included in medical insurance since March

Source: Western China Metropolis Daily February 4, 2015 medical network reported that CML drugs will be included in the scope of medical insurance reimbursement, which is the expectation of Wang Peng, a 29 year old patient in Sichuan Province The reporter learned on February 3 that on January 18 half a month ago, Sichuan Provincial Department of human resources and social security had issued a notice stipulating that CML would be officially included in the medical insurance since March 1, 2015 According to the notice, in order to reduce the burden of CML patients' medical expenses, all the insured persons who participate in the basic medical insurance for employees, urban residents and urban and rural residents who have realized the basic medical insurance in urban and rural areas as a whole will be included in the basic medical insurance fund of each area as a whole Scope, the reimbursement proportion is 75% Staff of Sichuan Provincial Department of human resources and social security confirmed the news to reporters on March 3 Domestic "generic drugs" are also expected to be included in the medical insurance of Gleevec, which is called life medicine for CML patients, and is one of the tyrosine kinase inhibitors According to the information released on the official website of the Ministry of human resources and social security, at least 15 provinces and cities including Guangdong, Jiangsu and Hainan have included Swiss Gleevec in the scope of medical insurance payment When it is not included in the medical insurance, it will cost 72000 yuan in total according to the "3 + 9" Assistance Project (purchase of three-month drugs and delivery of nine month drugs) carried out by China Charity Federation After being included in the medical insurance, 75% of the reimbursement will be removed, and 18000 yuan will be needed a year, which is 54000 yuan less than that before being included in the medical insurance According to the news released by Sichuan Charity Federation, since 2003, the "3 + 9" assistance project has been carried out in cooperation with China Charity Federation As of June 2014, more than 1400 patients in Sichuan Province have distributed medicines of Gleevec and Daxina, with the aid amount of more than 574.71 million yuan This means that long-term use of Gleevec in urban CML patients will benefit In February 2013, the Department of health of Sichuan Province has included 20 major diseases such as CML into the scope of NCMS major diseases payment by disease, and 70% of the expenses incurred within the specified limit shall be paid by NCMS fund On March 1 this year, after CML expenditure was covered by medical insurance, both urban and rural residents can enjoy preferential policies on reimbursement Data shows that there are nearly 100000 CML patients in China, with an annual increase of about 13000 Although after the medical insurance is included, the annual cost of the genuine Gleevec is only about 20000 yuan, which is still a great burden for many families At present, the generic drugs of Gleevec have been produced in China, and the monthly cost is about 3000 yuan If included in the medical insurance, the annual cost will be less than 10000 yuan Yesterday (3), a Sichuan CML patient told reporters that he consulted the social security department of the human resources and social security department and learned that generic drugs contain tyrosine kinase inhibitors, so they can also be included in the scope of medical insurance However, a number of patients in Sichuan said, "after all, domestic drugs are late on the market, and its effect remains to be observed." More patients in Sichuan are quietly calculating accounts Even if genuine drugs and domestic generic drugs are included in the medical insurance, the cost of generic drugs in India is still less than that of 2000-3000 yuan a year.